Full View

Economic outcomes of antiobesity medication use among adults in the United States: a retrospective cohort study

S Watkins, JC Toliver, N Kim, S Whitmire… - Journal of managed care …, 2022 - jmcp.org
BACKGROUND: Obesity prevalence exceeds 40% in the US adult population, posing a
substantial burden on the health care system. Antiobesity medication (AOM) is …
被引用次数：6 相关文章

Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study

S Watkins, JC Toliver, N Kim, S Whitmire… - … to an area of the ileum to …, 2022 - jmcp.org
ABSTRACT BACKGROUND: Obesity prevalence exceeds 40% in the US adult population,
posing a substantial burden on the health care system. Antiobesity medication (AOM) is …

Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study

S Watkins, JC Toliver, N Kim… - … of managed care …, 2022 - pubmed.ncbi.nlm.nih.gov
BACKGROUND: Obesity prevalence exceeds 40% in the US adult population, posing a
substantial burden on the health care system. Antiobesity medication (AOM) is …